Pre-eclampsia: universal screening or universal prevention for low and middle-income settings?
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UFMG |
Texto Completo: | https://doi.org/10.1055/s-0040-1713803 http://hdl.handle.net/1843/55166 https://orcid.org/0000-0002-8422-9907 https://orcid.org/0000-0001-8476-6326 https://orcid.org/0000-0003-1767-4725 https://orcid.org/0000-0001-8100-1926 https://orcid.org/0000-0003-0761-7700 https://orcid.org/0000-0001-5345-3861 https://orcid.org/0000-0002-3789-885X https://orcid.org/0000-0001-8280-3234 https://orcid.org/0000-0003-4198-0546 https://orcid.org/0000-0001-7187-1004 https://orcid.org/0000-0001-5010-4914 https://orcid.org/0000-0003-0565-9747 https://orcid.org/0000-0002-3273-3001 |
Resumo: | Pre-eclampsia (PE) is a severe disorder that affects up to 8% of all pregnancies and represents an important cause of maternal and perinatal morbidity and mortality. The screening of the disease is a subject of studies, but the complexity and uncertainties regarding its etiology make this objective a difficult task. In addition, the costs related to screening protocols, the heterogeneity of the most affected populations and the lack of highly effective prevention methods reduce the potential of current available algorithms for screening. Thus, the National Specialized Commission of Hypertension in Pregnancy of the Brazilian Association of Gynecology and Obstetrics Federation (Febrasgo, in the Portuguese acronym) (NSC Hypertension in Pregnancy of the Febrasgo) considers that there are no screening algorithms to be implemented in the country to date and advocates that Aspirin and calcium should be widely used. |
id |
UFMG_7e919984da6cecccf9a4265479656f08 |
---|---|
oai_identifier_str |
oai:repositorio.ufmg.br:1843/55166 |
network_acronym_str |
UFMG |
network_name_str |
Repositório Institucional da UFMG |
repository_id_str |
|
spelling |
2023-06-20T19:19:29Z2023-06-20T19:19:29Z20214316165https://doi.org/10.1055/s-0040-17138030100-7203http://hdl.handle.net/1843/55166https://orcid.org/0000-0002-8422-9907https://orcid.org/0000-0001-8476-6326https://orcid.org/0000-0003-1767-4725https://orcid.org/0000-0001-8100-1926https://orcid.org/0000-0003-0761-7700https://orcid.org/0000-0001-5345-3861https://orcid.org/0000-0002-3789-885Xhttps://orcid.org/0000-0001-8280-3234https://orcid.org/0000-0003-4198-0546https://orcid.org/0000-0001-7187-1004https://orcid.org/0000-0001-5010-4914https://orcid.org/0000-0003-0565-9747https://orcid.org/0000-0002-3273-3001Pre-eclampsia (PE) is a severe disorder that affects up to 8% of all pregnancies and represents an important cause of maternal and perinatal morbidity and mortality. The screening of the disease is a subject of studies, but the complexity and uncertainties regarding its etiology make this objective a difficult task. In addition, the costs related to screening protocols, the heterogeneity of the most affected populations and the lack of highly effective prevention methods reduce the potential of current available algorithms for screening. Thus, the National Specialized Commission of Hypertension in Pregnancy of the Brazilian Association of Gynecology and Obstetrics Federation (Febrasgo, in the Portuguese acronym) (NSC Hypertension in Pregnancy of the Febrasgo) considers that there are no screening algorithms to be implemented in the country to date and advocates that Aspirin and calcium should be widely used.A Pré-eclâmpsia (PE) é uma doença grave que acomete ~ 8% das gestações e representa importante causa de morbimortalidade, tanto materna quanto perinatal. O rastreamento da doença é motivo de estudos, porém a complexidade e as incertezas quanto a sua etiologia tornam esse objetivo bastante difícil. Além disso, os custos relacionados com o rastreamento, a heterogeneidade das populações mais afetadas e ainda a falta de métodos de prevenção de grande eficácia reduzem o potencial dos algoritmos de rastreamento. Assim, a Comissão Nacional Especializada sobre Hipertensão na Gravidez da Federação Brasileira das Associações de Ginecologia e Obstetrícia (CNE Hipertensão na Gravidez da FEBRASGO) considera que não há algoritmos de rastreamento que possam ser aplicados no país nesse momento e defende a utilização dos métodos de prevenção como ácido acetilsalicílico e cálcio de maneira ampla.Outra AgênciaengUniversidade Federal de Minas GeraisUFMGBrasilHCL - HOSPITAL DAS CLINICASMED - DEPARTAMENTO DE GINECOLOGIA OBSTETRÍCIARevista Brasileira de Ginecologia e ObstetríciaPré-eclâmpsiaCuidado pré-natalAspirinaCálcioPreeclampsiaScreeningPreventionAspirinCalciumPre-eclampsia: universal screening or universal prevention for low and middle-income settings?Pré-eclâmpsia: rastreamento universal ou prevenção universal para países de baixa e média-renda?info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttps://www.thieme-connect.de/products/ejournals/abstract/10.1055/s-0040-1713803Leandro Gustavo de OliveiraAngélica Lemos Debs DinizCaio Antônio de Campos PradoEdson Vieira da Cunha FilhoFrancisco Lázaro Pereira de SouzaHenri Augusto KorkesJosé Geraldo Lopes RamosMaria Laura CostaMário Dias Corrêa JuniorNelson SassRicardo de Carvalho CavalliSérgio Hofmeister de Almeida Martins CostaJosé Carlos Peraçoliapplication/pdfinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFMGinstname:Universidade Federal de Minas Gerais (UFMG)instacron:UFMGLICENSELicense.txtLicense.txttext/plain; charset=utf-82042https://repositorio.ufmg.br/bitstream/1843/55166/1/License.txtfa505098d172de0bc8864fc1287ffe22MD51ORIGINALPre-eclampsia universal screening or universal prevention for low and middle-income settings.pdfPre-eclampsia universal screening or universal prevention for low and middle-income settings.pdfapplication/pdf111559https://repositorio.ufmg.br/bitstream/1843/55166/2/Pre-eclampsia%20universal%20screening%20or%20universal%20prevention%20for%20low%20and%20middle-income%20settings.pdf6183c130e02c4b3d44b2297705dd367cMD521843/551662023-06-20 16:19:30.135oai:repositorio.ufmg.br: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Repositório de PublicaçõesPUBhttps://repositorio.ufmg.br/oaiopendoar:2023-06-20T19:19:30Repositório Institucional da UFMG - Universidade Federal de Minas Gerais (UFMG)false |
dc.title.pt_BR.fl_str_mv |
Pre-eclampsia: universal screening or universal prevention for low and middle-income settings? |
dc.title.alternative.pt_BR.fl_str_mv |
Pré-eclâmpsia: rastreamento universal ou prevenção universal para países de baixa e média-renda? |
title |
Pre-eclampsia: universal screening or universal prevention for low and middle-income settings? |
spellingShingle |
Pre-eclampsia: universal screening or universal prevention for low and middle-income settings? Leandro Gustavo de Oliveira Preeclampsia Screening Prevention Aspirin Calcium Pré-eclâmpsia Cuidado pré-natal Aspirina Cálcio |
title_short |
Pre-eclampsia: universal screening or universal prevention for low and middle-income settings? |
title_full |
Pre-eclampsia: universal screening or universal prevention for low and middle-income settings? |
title_fullStr |
Pre-eclampsia: universal screening or universal prevention for low and middle-income settings? |
title_full_unstemmed |
Pre-eclampsia: universal screening or universal prevention for low and middle-income settings? |
title_sort |
Pre-eclampsia: universal screening or universal prevention for low and middle-income settings? |
author |
Leandro Gustavo de Oliveira |
author_facet |
Leandro Gustavo de Oliveira Angélica Lemos Debs Diniz Caio Antônio de Campos Prado Edson Vieira da Cunha Filho Francisco Lázaro Pereira de Souza Henri Augusto Korkes José Geraldo Lopes Ramos Maria Laura Costa Mário Dias Corrêa Junior Nelson Sass Ricardo de Carvalho Cavalli Sérgio Hofmeister de Almeida Martins Costa José Carlos Peraçoli |
author_role |
author |
author2 |
Angélica Lemos Debs Diniz Caio Antônio de Campos Prado Edson Vieira da Cunha Filho Francisco Lázaro Pereira de Souza Henri Augusto Korkes José Geraldo Lopes Ramos Maria Laura Costa Mário Dias Corrêa Junior Nelson Sass Ricardo de Carvalho Cavalli Sérgio Hofmeister de Almeida Martins Costa José Carlos Peraçoli |
author2_role |
author author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Leandro Gustavo de Oliveira Angélica Lemos Debs Diniz Caio Antônio de Campos Prado Edson Vieira da Cunha Filho Francisco Lázaro Pereira de Souza Henri Augusto Korkes José Geraldo Lopes Ramos Maria Laura Costa Mário Dias Corrêa Junior Nelson Sass Ricardo de Carvalho Cavalli Sérgio Hofmeister de Almeida Martins Costa José Carlos Peraçoli |
dc.subject.por.fl_str_mv |
Preeclampsia Screening Prevention Aspirin Calcium |
topic |
Preeclampsia Screening Prevention Aspirin Calcium Pré-eclâmpsia Cuidado pré-natal Aspirina Cálcio |
dc.subject.other.pt_BR.fl_str_mv |
Pré-eclâmpsia Cuidado pré-natal Aspirina Cálcio |
description |
Pre-eclampsia (PE) is a severe disorder that affects up to 8% of all pregnancies and represents an important cause of maternal and perinatal morbidity and mortality. The screening of the disease is a subject of studies, but the complexity and uncertainties regarding its etiology make this objective a difficult task. In addition, the costs related to screening protocols, the heterogeneity of the most affected populations and the lack of highly effective prevention methods reduce the potential of current available algorithms for screening. Thus, the National Specialized Commission of Hypertension in Pregnancy of the Brazilian Association of Gynecology and Obstetrics Federation (Febrasgo, in the Portuguese acronym) (NSC Hypertension in Pregnancy of the Febrasgo) considers that there are no screening algorithms to be implemented in the country to date and advocates that Aspirin and calcium should be widely used. |
publishDate |
2021 |
dc.date.issued.fl_str_mv |
2021 |
dc.date.accessioned.fl_str_mv |
2023-06-20T19:19:29Z |
dc.date.available.fl_str_mv |
2023-06-20T19:19:29Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/1843/55166 |
dc.identifier.doi.pt_BR.fl_str_mv |
https://doi.org/10.1055/s-0040-1713803 |
dc.identifier.issn.pt_BR.fl_str_mv |
0100-7203 |
dc.identifier.orcid.pt_BR.fl_str_mv |
https://orcid.org/0000-0002-8422-9907 https://orcid.org/0000-0001-8476-6326 https://orcid.org/0000-0003-1767-4725 https://orcid.org/0000-0001-8100-1926 https://orcid.org/0000-0003-0761-7700 https://orcid.org/0000-0001-5345-3861 https://orcid.org/0000-0002-3789-885X https://orcid.org/0000-0001-8280-3234 https://orcid.org/0000-0003-4198-0546 https://orcid.org/0000-0001-7187-1004 https://orcid.org/0000-0001-5010-4914 https://orcid.org/0000-0003-0565-9747 https://orcid.org/0000-0002-3273-3001 |
url |
https://doi.org/10.1055/s-0040-1713803 http://hdl.handle.net/1843/55166 https://orcid.org/0000-0002-8422-9907 https://orcid.org/0000-0001-8476-6326 https://orcid.org/0000-0003-1767-4725 https://orcid.org/0000-0001-8100-1926 https://orcid.org/0000-0003-0761-7700 https://orcid.org/0000-0001-5345-3861 https://orcid.org/0000-0002-3789-885X https://orcid.org/0000-0001-8280-3234 https://orcid.org/0000-0003-4198-0546 https://orcid.org/0000-0001-7187-1004 https://orcid.org/0000-0001-5010-4914 https://orcid.org/0000-0003-0565-9747 https://orcid.org/0000-0002-3273-3001 |
identifier_str_mv |
0100-7203 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.ispartof.pt_BR.fl_str_mv |
Revista Brasileira de Ginecologia e Obstetrícia |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade Federal de Minas Gerais |
dc.publisher.initials.fl_str_mv |
UFMG |
dc.publisher.country.fl_str_mv |
Brasil |
dc.publisher.department.fl_str_mv |
HCL - HOSPITAL DAS CLINICAS MED - DEPARTAMENTO DE GINECOLOGIA OBSTETRÍCIA |
publisher.none.fl_str_mv |
Universidade Federal de Minas Gerais |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFMG instname:Universidade Federal de Minas Gerais (UFMG) instacron:UFMG |
instname_str |
Universidade Federal de Minas Gerais (UFMG) |
instacron_str |
UFMG |
institution |
UFMG |
reponame_str |
Repositório Institucional da UFMG |
collection |
Repositório Institucional da UFMG |
bitstream.url.fl_str_mv |
https://repositorio.ufmg.br/bitstream/1843/55166/1/License.txt https://repositorio.ufmg.br/bitstream/1843/55166/2/Pre-eclampsia%20universal%20screening%20or%20universal%20prevention%20for%20low%20and%20middle-income%20settings.pdf |
bitstream.checksum.fl_str_mv |
fa505098d172de0bc8864fc1287ffe22 6183c130e02c4b3d44b2297705dd367c |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da UFMG - Universidade Federal de Minas Gerais (UFMG) |
repository.mail.fl_str_mv |
|
_version_ |
1803589264223502336 |